The unrelenting growth of diabetes around the world is prompting cardiologists to rethink how they treat and manage a challenging patient population, even as an emerging class of cardio-protective diabetes drugs is setting the stage for transformation.

A 51-year-old man suffered a “massive” heart attack in East Oahu moments after Hawaiian officials issued a false missile alert last weekend, the Honolulu Star-Advertiser reported.

International Biophysics Corporation, a global medical device manufacturer based in Austin, Texas, announced they have received FDA 510k clearance for their FloPump 32 centrifugal disposable heart pump.

The FDA issued a safety alert Jan. 17 for the Zoll LifeVest 4000, saying the external, wearable cardioverter defibrillator may fail to treat potentially fatal arrhythmias if it displays a specific error message which, by itself, doesn’t signal urgency.

Next-day discharge after minimalist transcatheter aortic valve replacement (TAVR) was safe for patients who didn’t experience perioperative complications and was linked to better one-year outcomes versus patients discharged later, according to a single-center study published in JACC: Cardiovascular Interventions.

Breastfeeding for at least a year could reduce a new mom’s risk of diabetes by 47 percent, the New York Times has reported.

Nearly a quarter of patients with chronic ischemic cardiovascular disease are either dead or rehospitalized within six months of their diagnosis, according to a Jan. 17 report published in the European Journal of Preventive Cardiology.

Stroke may be linked to an increased risk of dementia, but cognitive decline isn’t an inevitable consequence of the event, researchers reported in the Journal of the American Heart Association this week.